Singapore’s property firm CapitaLand Group (CapitaLand) has on Friday officially opened Geneo, a life sciences and innovation hub at Singapore Science Park (SSP) with about S$1.4 billion ($1.09 billion) investments.
The opening marks a key milestone in CapitaLand’s multiphase rejuvenation of Singapore’s first research and development (R&D) and technology park, the firm said in a statement.
Geneo is jointly owned by CapitaLand Development (CLD) and CapitaLand Ascendas REIT (CLAR).
Geneo spans three properties, 1 Science Park Drive, 5 Science Park Drive and 7 Science Park Drive, with a total gross floor area (GFA) of approximately 180,600 square metres (sqm).
This includes approximately 80,000 sqm of purpose-built infrastructure for biomedical R&D, flexible laboratories and innovation-ready Grade A business park workspaces.
“As a life sciences and innovation hub, it supports the full innovation cycle, from research through to commercialization, within an integrated environment,” said Jonathan Yap, Chief Executive Officer of CLD, the master developer and park operator of SSP.
William Tay, Chief Executive Officer and Executive Director of the manager of CLAR, said these high-quality properties are seeing strong tenancy demand from world-leading companies in biomedical sciences, R&D and technology sectors, further reinforcing CLAR’s leadership position in Singapore’s life sciences real estate market.
“With a portfolio of approximately 4.5 million square feet of properties at Singapore Science Park, CLAR is the largest provider of business park and life sciences space within the precinct,” he added.
According to the statement, Geneo has attracted tenants, including Agency for Science, Technology and Research (A*STAR), Barry Callebaut, Chugai Pharmabody Research, Henkel, and NSG Bio, spanning industries from biotech and advanced manufacturing to food innovation, and pharmaceutical R&D.
Their presence at Geneo underscores confidence in CapitaLand’s capabilities in best-in-class developments that support a wide range of R&D activities and innovation needs.
It also reinforces CapitaLand’s role as an ecosystem curator, connecting Singapore-based researchers, start-ups and corporates with global partners, investors as well as institutions.
The specialized infrastructure at Geneo includes wet lab and wet lab-ready floors, coworking laboratory space, units with tailored specifications such as high floor loading, and smart building management systems.
There are also communal spaces and active placemaking programs that encourage cross-disciplinary collaborations.
The life sciences and innovation community at Geneo is further enabled by Bridge+ Geneo.
It provides premium flexible workspaces and NSG BioSuites, CapitaLand’s first coworking laboratory facility in partnership with NSG Bio.
The facility is Southeast Asia’s largest coworking laboratory which spans over 3,200 square meters (nearly 35,000 square feet).
Together, they form The Apex, where researchers, start-ups, corporates and investors connect and scale-up.
These facilities support a life science enterprise’s full journey from discovery and experimentation to team growth and industry deployment.
Geneo also achieved the Building and Construction Authority’s (BCA) Green Mark Platinum rating for all three properties, including Super Low Energy for 7 Science Park Drive.